{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:28:24Z","timestamp":1769552904864,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of South Africa","award":["grant no. 137965"],"award-info":[{"award-number":["grant no. 137965"]}]},{"name":"Poliomyelitis Research Foundation of South Africa","award":["grant no. 23\/78"],"award-info":[{"award-number":["grant no. 23\/78"]}]},{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"crossref","award":["SIR grant"],"award-info":[{"award-number":["SIR grant"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The novel coronavirus disease of 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Data from the COVID-19 clinical control case studies showed that this disease could also manifest in patients with underlying microbial infections such as aspergillosis. The current study aimed to determine if the <jats:italic>Aspergillus<\/jats:italic> (<jats:italic>A.<\/jats:italic>) <jats:italic>fumigatus<\/jats:italic> culture media (i.e., supernatant) possessed protease activity that was sufficient to activate the SARS-CoV-2 spike protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The supernatant was first analysed for protease activity. Thereafter, it was assessed to determine if it possessed proteolytic activity to cleave a fluorogenic mimetic peptide of the SARS-CoV-2 spike protein that contained the S1\/S2 site and a full-length spike protein contained in a SARS-CoV-2 pseudovirion. To complement this, a computer-based tool, HADDOCK, was used to predict if <jats:italic>A. fumigatus<\/jats:italic> alkaline protease 1 could bind to the SARS-CoV-2 spike protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We show that the supernatant possessed proteolytic activity, and analyses of the molecular docking parameters revealed that <jats:italic>A. fumigatus<\/jats:italic> alkaline protease 1 could bind to the spike protein. To confirm the <jats:italic>in silico<\/jats:italic> data, it was imperative to provide experimental evidence for enzymatic activity. Here, it was noted that the <jats:italic>A. fumigatus<\/jats:italic> supernatant cleaved the mimetic peptide as well as transduced the HEK-293T cells with SARS-CoV-2 pseudovirions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest that <jats:italic>A. fumigatus<\/jats:italic> secretes a protease(s) that activates the SARS-CoV-2 spike protein. Importantly, should these two infectious agents co-occur, there is the potential for <jats:italic>A. fumigatus<\/jats:italic> to activate the SARS-CoV-2 spike protein, thus aggravating COVID-19 development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-024-02331-z","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T16:02:06Z","timestamp":1709740926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aspergillus fumigatus secretes a protease(s) that displays in silico binding affinity towards the SARS-CoV-2 spike protein and mediates SARS-CoV-2 pseudovirion entry into HEK-293T cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Nozethu","family":"Mjokane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric O.","family":"Akintemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saheed","family":"Sabiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onele M. N.","family":"Gcilitshana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus","family":"Albertyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina H.","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olihile M.","family":"Sebolai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"2331_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/emp2.12034","volume":"1","author":"J Yee","year":"2020","unstructured":"Yee J, Unger L, Zadravecz F, Cariello P, Seibert A, Johnson MA, et al. Novel coronavirus 2019 (COVID-19): emergence and implications for emergency care. J Am Coll Emerg Physicians Open. 2020;1:63\u20139. https:\/\/doi.org\/10.1002\/emp2.12034.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"2331_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1148\/radiol.2020200274","volume":"295","author":"F Song","year":"2020","unstructured":"Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiol. 2020;295:210\u20137. https:\/\/doi.org\/10.1148\/radiol.2020200274.","journal-title":"Radiol"},{"key":"2331_CR3","unstructured":"WHO COVID-19 Dashboard. Geneva: World Health Organization., 2020. Available online: https:\/\/covid19.who.int\/ (accessed 15 December 2023)."},{"key":"2331_CR4","doi-asserted-by":"publisher","first-page":"681469","DOI":"10.3389\/fmed.2021.681469","volume":"8","author":"M Dadashi","year":"2021","unstructured":"Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, et al. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med. 2021;8:681469. https:\/\/doi.org\/10.3389\/fmed.2021.681469.","journal-title":"Front Med"},{"key":"2331_CR5","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.micpath.2021.104941","volume":"156","author":"MN Hoque","year":"2021","unstructured":"Hoque MN, Akter S, Mishu ID, Islam MR, Rahman MS, Akhter M, et al. Microbial co- infections in COVID-19: Associated Microbiota and underlying mechanisms of pathogenesis. Microb Pathog. 2021;156:104941. https:\/\/doi.org\/10.1016\/j.micpath.2021.104941.","journal-title":"Microb Pathog"},{"key":"2331_CR6","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","volume":"184","author":"B Sposito","year":"2021","unstructured":"Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell. 2021;184:4953\u201368. https:\/\/doi.org\/10.1016\/j.cell.2021.08.016.","journal-title":"Cell"},{"key":"2331_CR7","doi-asserted-by":"publisher","first-page":"e00094","DOI":"10.1128\/cmr.00094-21","volume":"35","author":"F Salazar","year":"2022","unstructured":"Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of respiratory viral and fungal coinfections. Clin Microbiol Rev. 2022;35:e00094\u201321. https:\/\/doi.org\/10.1128\/cmr.00094-21.","journal-title":"Clin Microbiol Rev"},{"key":"2331_CR8","doi-asserted-by":"publisher","unstructured":"Morton CO, Griffiths JS, Loeffler J, Orr S, White PL. Defective antifungal immunity in patients with COVID-19. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1080822","DOI":"10.3389\/fimmu.2022.1080822"},{"key":"2331_CR9","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.micinf.2009.07.002","volume":"11","author":"V Balloy","year":"2009","unstructured":"Balloy V, Chignard M. The innate immune response to Aspergillus Fumigatus. Microbes Infect. 2009;11:919\u201327. https:\/\/doi.org\/10.1016\/j.micinf.2009.07.002.","journal-title":"Microbes Infect"},{"key":"2331_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fimmu.2020.01041","volume":"11","author":"J Bigot","year":"2020","unstructured":"Bigot J, Guillot L, Guitard J, Ruffin M, Corvol H, Balloy V, et al. Bronchial epithelial cells on the front line to fight lung infection-causing aspergillus fumigatus. Front Immunol. 2020;11:1041. https:\/\/doi.org\/10.3389\/fimmu.2020.01041.","journal-title":"Front Immunol"},{"key":"2331_CR11","unstructured":"World Health Organization, WHO fungal priority pathogens list to guide research development and public health action. 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240060241."},{"key":"2331_CR12","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1086\/420850","volume":"189","author":"TV Kogan","year":"2004","unstructured":"Kogan TV, Jadoun J, Mittelman L, Hirschberg K, Osherov N. Involvement of secreted aspergillus fumigatus proteases in disruption of the actin fiber cytoskeleton and loss of focal adhesion sites in infected A549 lung pneumocytes. J Infect Dis. 2004;189:1965\u201373. https:\/\/doi.org\/10.1086\/420850.","journal-title":"J Infect Dis"},{"key":"2331_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.funbio.2012.07.004","volume":"116","author":"E Farnell","year":"2012","unstructured":"Farnell E, Rousseau K, Thornton DJ, Bowyer P, Herrick SE. Expression and secretion of aspergillus fumigatus proteases are regulated in response to different protein substrates. Fungal Biol. 2012;116:1003\u201312. https:\/\/doi.org\/10.1016\/j.funbio.2012.07.004.","journal-title":"Fungal Biol"},{"key":"2331_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/jof6020088","volume":"6","author":"KM Druey","year":"2020","unstructured":"Druey KM, McCullough M, Krishnan R. Aspergillus fumigatus protease alkaline protease 1 (Alp1): a new therapeutic target for fungal asthma. J Fungi. 2020;6:88. https:\/\/doi.org\/10.3390\/jof6020088.","journal-title":"J Fungi"},{"key":"2331_CR15","doi-asserted-by":"publisher","first-page":"e1009225","DOI":"10.1371\/journal.ppat.1009225","volume":"17","author":"N Murgolo","year":"2021","unstructured":"Murgolo N, Therien AG, Howell B, Klein D, Koeplinger K, Lieberman LA, et al. SARS- CoV-2 tropism, entry, replication, and propagation: considerations for drug discovery and development. PLoS Pathog. 2021;17:e1009225. https:\/\/doi.org\/10.1371\/journal.ppat.1009225.","journal-title":"PLoS Pathog"},{"key":"2331_CR16","doi-asserted-by":"publisher","first-page":"587269","DOI":"10.3389\/fcimb.2020.587269","volume":"10","author":"MY Wang","year":"2020","unstructured":"Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269. https:\/\/doi.org\/10.3389\/fcimb.2020.587269.","journal-title":"Front Cell Infect Microbiol"},{"key":"2331_CR17","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1021\/acs.jproteome.0c00430","volume":"19","author":"B Luan","year":"2020","unstructured":"Luan B, Huynh T, Cheng X, Lan G, Wang HR. Targeting proteases for treating COVID- 19. J Proteome Res. 2020;19:4316\u201326. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00430","journal-title":"J Proteome Res"},{"key":"2331_CR18","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1002\/anie.200604205","volume":"46","author":"MD Toscano","year":"2007","unstructured":"Toscano MD, Woycechowsky KJ, Hilvert D. Minimalist active-site redesign: teaching old enzymes new tricks. Angew Chem Int Ed. 2007;46:3212\u201336. https:\/\/doi.org\/10.1002\/anie.200604205.","journal-title":"Angew Chem Int Ed"},{"key":"2331_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1126\/science.2683070","volume":"246","author":"RS Fuller","year":"1989","unstructured":"Fuller RS, Brake AJ, Thorner J. Intracellular targeting and structural conservation of a prohormone-processing endoprotease. Science. 1989;246:482\u20136. https:\/\/doi.org\/10.1126\/science.2683070.","journal-title":"Science"},{"key":"2331_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.fgb.2015.02.006","volume":"76","author":"J Wang","year":"2015","unstructured":"Wang J, Zhou H, Lu H, Du T, Luo Y, Wilson IB, Jin C. Kexin-like endoprotease KexB is required for N-glycan processing, morphogenesis and virulence in aspergillus fumigatus. Fungal Genet Biol. 2015;76:57\u201369. https:\/\/doi.org\/10.1016\/j.fgb.2015.02.006.","journal-title":"Fungal Genet Biol"},{"key":"2331_CR21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2108\/zsj.20.1183","volume":"20","author":"S Tanaka","year":"2003","unstructured":"Tanaka S. Comparative aspects of intracellular proteolytic processing of peptide hormone precursors: studies of proopiomelanocortin processing. Zoolog Sci. 2003;20:1183\u201398. https:\/\/doi.org\/10.2108\/zsj.20.1183.","journal-title":"Zoolog Sci"},{"key":"2331_CR22","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1083\/jcb.111.6.2851","volume":"111","author":"PA Bresnahan","year":"1990","unstructured":"Bresnahan PA, Leduc R, Thomas L, Thorner J, Gibson HL, Brake AJ, Barr PJ, Thomas G. Human FUR gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol. 1990;111:2851\u20139. https:\/\/doi.org\/10.1083\/jcb.111.6.2851.","journal-title":"J Cell Biol"},{"key":"2331_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/metabo12100982","volume":"12","author":"JO Aribisala","year":"2022","unstructured":"Aribisala JO, Aruwa CE, Uthman TO, Nurain IO, Idowu K, Sabiu S. Cheminformatics bioprospection of broad spectrum plant secondary metabolites targeting the spike proteins of omicron variant and wild-type SARS-CoV-2. Metabolites. 2022;12:982. https:\/\/doi.org\/10.3390\/metabo12100982.","journal-title":"Metabolites"},{"key":"2331_CR24","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","volume":"125","author":"C Dominguez","year":"2003","unstructured":"Dominguez C, Boelens R, Bonvin AM. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc. 2003;125:1731\u20137. https:\/\/doi.org\/10.1021\/ja026939x.","journal-title":"J Am Chem Soc"},{"key":"2331_CR25","doi-asserted-by":"publisher","first-page":"358892","DOI":"10.3791\/58892","volume":"143","author":"JA Jaimes","year":"2019","unstructured":"Jaimes JA, Millet JK, Goldstein ME, Whittaker GR, Straus MR. A fluorogenic peptide cleavage assay to screen for proteolytic activity: applications for coronavirus spike protein activation. J Vis Exp. 2019;143:358892. https:\/\/doi.org\/10.3791\/58892.","journal-title":"J Vis Exp"},{"key":"2331_CR26","doi-asserted-by":"publisher","first-page":"101212","DOI":"10.1016\/j.isci.2020.101212","volume":"23","author":"JA Jaimes","year":"2020","unstructured":"Jaimes JA, Millet JK, Whittaker GR. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1\/S2 site. iScience. 2020;23:101212. https:\/\/doi.org\/10.1016\/j.isci.2020.101212.","journal-title":"iScience"},{"key":"2331_CR27","doi-asserted-by":"publisher","unstructured":"Izidoro MA, Gouvea IE, Santos JA, Assis DM, Oliveira V, Judice WA. A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ion Arch Biochem Biophy. 2009; 487: 105\u201314. https:\/\/doi.org\/10.1016\/j.abb.2009.05.013.","DOI":"10.1016\/j.abb.2009.05.013"},{"key":"2331_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.p1041","volume":"381","author":"J Wise","year":"2023","unstructured":"Wise J. WHO declares end to COVID-19 as Global Health Emergency. BMJ. 2023;381:1041. https:\/\/doi.org\/10.1136\/bmj.p1041.","journal-title":"BMJ"},{"key":"2331_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","volume":"54","author":"CC Lai","year":"2021","unstructured":"Lai CC, Yu WL. COVID-19 associated with pulmonary aspergillosis: a literature review. J Microbiol Immunol Infect. 2021;54:46\u201353. https:\/\/doi.org\/10.1016\/j.jmii.2020.09.004.","journal-title":"J Microbiol Immunol Infect"},{"key":"2331_CR30","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1021\/acs.jpclett.0c01698","volume":"11","author":"N Vankadari","year":"2020","unstructured":"Vankadari N. Structure of furin protease binding to SARS-CoV-2 spike glycoprotein and implications for potential targets and virulence. J Phys Chem Lett. 2020;11:6655\u201363. https:\/\/doi.org\/10.1021\/acs.jpclett.0c01698.","journal-title":"J Phys Chem Lett"},{"key":"2331_CR31","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1021\/acs.jmedchem.1c00518","volume":"65","author":"EEA Osman","year":"2021","unstructured":"Osman EEA, Rehemtulla A, Neamati N. Why all the fury over furin? J Med Chem. 2021;65:2747\u201384. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00518.","journal-title":"J Med Chem"},{"key":"2331_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jtcme.2021.01.006","volume":"11","author":"F Rahman","year":"2021","unstructured":"Rahman F, Tabrez S, Ali R, Alqahtani AS, Ahmed MZ, Rub A. Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins. J Tradit Complement Med. 2021;11:173\u20139. https:\/\/doi.org\/10.1016\/j.jtcme.2021.01.006.","journal-title":"J Tradit Complement Med"},{"key":"2331_CR33","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1111\/j.1538-7836.2003.00421.x","volume":"1","author":"D Venkateswarlu","year":"2003","unstructured":"Venkateswarlu D, Duke RE, Perera L, Darden TA. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF\u2013VIIa\u2013Xa): a protein-protein docking and molecular dynamics refinement study. J Thromb Haemost. 2003;1:2577\u201388. https:\/\/doi.org\/10.1111\/j.1538-7836.2003.00421.x.","journal-title":"J Thromb Haemost"},{"key":"2331_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/biology10100966","volume":"10","author":"N Mjokane","year":"2021","unstructured":"Mjokane N, Folorunso OS, Ogundeji AO, Sebolai OM. The possible role of microbial proteases in facilitating SARS-CoV-2 brain invasion. Biology. 2021;10:966. https:\/\/doi.org\/10.3390\/biology10100966.","journal-title":"Biology"},{"key":"2331_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cells11030437","volume":"11","author":"N Mjokane","year":"2022","unstructured":"Mjokane N, Maliehe M, Folorunso OS, Ogundeji AO, Gcilitshana OM, Albertyn J, et al. Cryptococcal protease (s) and the activation of SARS-CoV-2 spike (S) protein. Cells. 2022;11:437. https:\/\/doi.org\/10.3390\/cells11030437.","journal-title":"Cells"},{"key":"2331_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fddsv.2022.899239","volume":"2","author":"BO Villoutreix","year":"2022","unstructured":"Villoutreix BO, Badiola I, Khatib AM, Furin. COVID-19: structure, function and chemoinformatic analysis of representative active site inhibitors. Frontiers. 2022;2:1\u20137. https:\/\/doi.org\/10.3389\/fddsv.2022.899239.","journal-title":"Frontiers"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02331-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02331-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02331-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T08:04:39Z","timestamp":1710057879000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02331-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02331-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}